Interestingly, the introduction of catalytically inactive mutant form of USP18 into USP18-depleted cancer cells did not show the same effect as the introduction of wild type USP18, indicating the importance of USP18 enzymatic activity in tumor progression [104]. The gene discussed is USP18; the disease is cancer.